Clinical and mutational spectrum of highly differentiated, PAX:FOXO1 fusion-negative rhabdomyosarcoma – a report from the Children’s Oncology Group

Background Pediatric PAX:FOXO1 fusion-negative rhabdomyosarcoma represents a diverse spectrum of tumors with marked differences in histology, myogenic differentiation and clinical behavior.